Delivery Order SPE2DB20D1100-SPE2DB25FD9V5
- Not listed
- The Defense Logistics Agency (DLA) awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 20 MG daily dose (60-count supply) with an ultimate completion date of August 19, 2025. This non-set-aside competitive award was issued on July 29, 2025, with performance to be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. LENVIMA is a targeted cancer therapy medication, reflecting the federal government's continued reliance on...
- The Defense Logistics Agency awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 8 mg daily dose (60-count supply) with an ultimate completion date of September 2, 2025. This non-set-aside contract was competitively awarded on August 11, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. LENVIMA (lenvatinib) is a targeted cancer therapy used in the treatment of various malignancies, reflecting the...
- The Defense Logistics Agency awarded a $10,223.24 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Lenvima 14 mg daily dose (60-count package), with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of LENVIMA 14 mg daily dose tablets (60-count packaging) with a contract ceiling value of $10,223.24. This competitive award, issued under a firm fixed price delivery order with no set-aside designation, is scheduled for ultimate completion on September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose tablets (30-count package) with an ultimate completion date of August 19, 2025. This non-competitive delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. LENVIMA is a targeted cancer therapy indicated for multiple malignancies, and this award reflects...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LENVIMA 18 mg daily dose tablets (90-count supply) valued at $10,223.24 under a firm fixed-price contract type. The award was made on August 8, 2025, with an ultimate completion date of August 29, 2025, and no set-aside designation was utilized. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery. This delivery order...
- The Defense Logistics Agency awarded a $10,223.24 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Lenvima 10 mg daily dose medication in 30-day quantities. This is a firm fixed price delivery order with no set-aside designation, scheduled for ultimate completion by September 3, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for the supply of Lenvima 8 mg daily dose in a quantity of 60 tablets. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 11, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made without a set-aside designation, reflecting open competition among eligible vendors. This delivery...
- The Defense Logistics Agency awarded a $10,223.24 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Lenvima 8 mg daily dose tablets (60-count supply) with a completion deadline of August 20, 2025. This firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation, reflecting...
- The Defense Logistics Agency's Medical Supply Chain awarded a $20.4K delivery order to AmerisourceBergen Drug Corp for the supply of LENVIMA 10 mg daily dose tablets (30-count packages) under a firm fixed price contract. The award, issued on August 4, 2025, with completion targeted for August 25, 2025, represents a non-competitive delivery order executed through the company's existing indefinite delivery contract (IDC) framework. Performance will be fulfilled from AmerisourceBergen's corporate...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD9V5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LENVIMA 8 mg daily dose in a quantity of 60 units, with a ceiling value of $10,223.24. This firm fixed-price delivery order, issued on August 11, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The product, LENVIMA, is a cancer treatment medication used for various oncological indications within military and veteran healthcare supply chains. This delivery order is structured under AmerisourceBergen Drug Corp's DLA Troop Support Medical indefinite delivery vehicle (SPE2DX), valued at $999,999,999.00 and active through December 2026, which provides comprehensive pharmaceutical support globally. The place of performance is identified as Conshohocken, Pennsylvania, and the contract is scheduled for ultimate completion by September 2, 2025. As a child contract under the larger IDC framework, this delivery order exemplifies AmerisourceBergen Drug Corp's role as a critical pharmaceutical prime vendor supporting military medical operations and federal healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 8/11/25 |